Capital University of Physical Education and Sports, Beijing, 100191, China.
BMC Palliat Care. 2024 Jun 13;23(1):147. doi: 10.1186/s12904-024-01439-x.
This study aimed to assess the therapeutic efficacy of Reiki therapy in alleviating anxiety.
In adherence to academic standards, a thorough search was conducted across esteemed databases such as PubMed, Web of Science, Science Direct, and the Cochrane Library. The primary objective of this search was to pinpoint peer-reviewed articles published in English that satisfied specific criteria: (1) employing an experimental or quasi-experimental study design, (2) incorporating Reiki therapy as the independent variable, (3) encompassing diverse patient populations along with healthy individuals, and (4) assessing anxiety as the measured outcome.
The study involved 824 participants, all of whom were aged 18 years or older. Reiki therapy was found to have a significant effect on anxiety intervention(SMD=-0.82, 95CI -1.29∼-0.36, P = 0.001). Subgroup analysis indicated that the types of subjects (chronically ill individuals and the general adult population) and the dosage/frequency of the intervention (≤ 3 sessions and 6-8 sessions) were significant factors influencing the variability in anxiety reduction.
Short-term Reiki therapy interventions of ≤ 3 sessions and 6-8 sessions have demonstrated effectiveness in reducing health and procedural anxiety in patients with chronic conditions such as gastrointestinal endoscopy inflammation, fibromyalgia, and depression, as well as in the general population. It is important to note that the efficacy of Reiki therapy in decreasing preoperative anxiety and death-related anxiety in preoperative patients and cancer patients is somewhat less consistent. These discrepancies may be attributed to individual pathophysiological states, psychological conditions, and treatment expectations.
本研究旨在评估灵气疗法缓解焦虑的疗效。
根据学术标准,我们在备受推崇的数据库(如 PubMed、Web of Science、Science Direct 和 Cochrane Library)中进行了全面搜索。该搜索的主要目的是找到以英语发表的符合特定标准的同行评议文章:(1)采用实验或准实验研究设计;(2)将灵气疗法作为独立变量;(3)纳入不同的患者群体和健康个体;(4)将焦虑作为测量结果。
研究涉及 824 名参与者,年龄均在 18 岁及以上。灵气疗法对焦虑干预有显著效果(SMD=-0.82,95CI-1.29∼-0.36,P=0.001)。亚组分析表明,受试者类型(慢性病患者和一般成年人群体)和干预的剂量/频率(≤3 次和 6-8 次)是影响焦虑减轻的显著因素。
短期灵气疗法干预(≤3 次和 6-8 次)在减轻慢性疾病患者(如胃肠道内窥镜炎症、纤维肌痛和抑郁症)和一般人群的健康和程序焦虑方面已被证明是有效的。需要注意的是,灵气疗法在降低术前患者和癌症患者的术前焦虑和与死亡相关的焦虑方面的疗效并不完全一致。这些差异可能归因于个体的病理生理状态、心理状况和治疗期望。